Morrish N.J., Stevens L.K., Fuller J.H., Jarret R.J. Incidence of macro- vascular disease in diabetes mellitus: The London cohort of the WHO Multinational Study of vascular Disease in Diabetics. Diabetología 1991; 34:584.
Cotran R.S., Munro J.M. Patogenia de la ateroesclerosis: Conceptos recientes. En Grundy S.M. y Bearn A.G. eds. El papel del colesterol en la ateroesclerosis. Nuevas posibilidades terapéuticas 1988; 5: Madrid. Jarpyo Editores.
Ross R. The pathogenesis of atheroesclerosis. An update. N. Engl. J. Med 1986; 314:488.
DaviesP.F., Dewey C.F. Jr., Bussdari S.R., GordonE.J., GimbroneM. A. Jr. Influence of hemodynamic forces on vascular endothelial function. J. Clin. Invest 1984; 73:1121.
Neaton J.D., Kuller L.H., Wentworth D., Borbani N.O. Total and cardiovascular mortality in relation to cigarette smoking, serum choleste- rol concentration, and diastolic blood pressure among black and white males follewed up five years. Am Heart J. 1984; 108:759.
Endemann G., Pronzcuk A., Friedman G. and cois. Monocyte adherence to endothelial cells in vitro is increased by B-VLDL. Am. J. Pathol 1987; 126:1.
Castellot J.J. Jr., Addonizio M.L., Rosenberg R.D., Kamovsky M.J. Cultured endothelial cells produce a heparin-like inhibitor of smooth muscle cell growth. J. Cell. Biol. 1981; 90:372.
Janka H.V., Stnadl E., Schramm W., Mehnert H. Platelet enzyme activities in diabetes mellitus in relation to endothelial damage. Diabetes 1983;32 Suppl 2: 47.
TothL., Szenasi P., Jambor G. and cols. Platelet function in male diabetics with and without macrovascualr complications. Diabetes Res. Clin. Pract. 1992; 15:143.
Guerrity R.G. The role of the monocyte in atherogenesis I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am. J. Pathol 1981; 103:181.
Gerrity R. G. The role of the monocyte in atherogenesis II. Migration of foam cells from atherosclerotic lesions. Am. J. Pathol 1981; 103:191.
Emst E., Dale E., Hanimerschidt M.D. and cois. Leykocytes and the risk of ischemic diseases. JAMA 1987,257:2318.
Quinn M.T., Parthasarathy s., Steinberg D. Endothelial cell derived chemotactic activity for macrophages and the effect of modiñed forms of LDL. Proc. Nati. Acad. Sci. 1985; USA-82:5949.
EichnerJ.E., KullerL.H., OrchardT.J. and cois. Relation of apolipopro- tein E phenotype to myocaridal infarction and mortality from coronary artery disease. Am.J. Cardiol 1993; 71:160.
Steiner G. Diabetes and Atherosclerosis. Anva review. Diabetes 1981 ;30 Suppl 2: 1.
Second European Consensus Document on Chronic Critical Leg Ischemic. Circulation 1991; Suppl. 84:4.
Bild D.E. and cois. Lower-extremity amputation in people with diabetes. Epidemiology and Prevention. Diabetes Care 1989; 12:24.
Reiber G.E., Pecorro R.E., Koepsell T.D. Risk factores for amputation in patients with diabetes mellitus. Ann. Int. Med. 1992; 117:97.
Morrish N.J., Stevens L.K., Fuller J.H. and cois. Risk factores for macrovascular disease in diabetes mellitus. The London follow up to the who Multinational Study of Vascular Disease in Diabetics. Diabetología 1991; 34:590.
Estrada Muñoz M., Garib Arbaje Z., Féliz Báez A. Prevalencia de la Hipertensión en la diabetes mellitus. Ciencia y Sociedad 1992; 17(2): 131- 140.
SchwartzG.L. Initial therapy for hypertension-Individualizing care. Mayo Clin. Proc. 1990; 65:73.
Aranz-Pacheco C. and Raskin P. Management of hypertension in diabetes. Endocrinol. Metb. clin. North Am. 1992; 21:371.
Earle K., Walker J., Hill C. and Viverti G. Familial clustering of cardiovascular disease in patients with insulin-dependent diabetes and nephropathy. N. Engl. J. Med. 1992; 326:675.
Karam J.H. Type II diabetes an Syndrome X. Pathogenesis and gíycemic management. Endocrinol. Metb. Clin. North Am. 1992; 21:329.
DeFronzo R.A., Bonadonna R.C., Ferranini E. Pathogenesis ofNIDDM. Diabetes Care 1992; 15-318.
Fonthonne A.M., Eschwege E.M. Insulin and cardiovascular disease. París Prospective Study. Diabetes Care 1991; 14:461.
Kostaba J., Dormán J. Orchord and cois. Contribution of diabetes dura- tion before puberty to development of microvascular complications in IDDM subjects. Diabetes Care 1989; 12:686.
Strowing S., Raskin P. Gíycemic control and diabetic complications. Diabetes Care 1992; 15:1126.
Laakso M., Barrett-Connor E. Asymptomatic hyperglycemic is associated with lipid and lipoprotein changes favoring atherosclerosis. Artherioescle- rosis 1989; 9:665.
Bergman M., Gidez L.I. eder H.A. High density lipoprotein subclasses in diabetes. Am. J. Med. 1986; 81:488.
Dunn F.L. Management of hyperlipidemia in diabetes mellitus. Endroci- nol. Metab. cin. North. Am. 1992; 21:395.
Valdivielso P., escobar J.L., Cuevas-Mons V. and cois. Lipids and lipoprotein changes after heart and liver transplantion in a patient with homizigous familial hypercholesterolemia. Ann. Int. Med. 1988; 108:204.
Assmann G., Schulte H. Thyglicerides and atherosclerosis. Results from the Prospective Cardiovascular Munster Study. Atherosclerosis Rev. 1991; 22:51.
Fracchini F.S., Hollenbeck c.B. Jeppesen J. and cois. Insulin resitance and cigarette smoking. Lancet 1992; 339:1128.
Raskin P. Cómo tratar la hipertensión en pacientes diabéticos. Trib. Med. 1991; 48:5.
Hughes T.A., Guynne J.T., switzer B.R. and cois. Effects of caloric restriction and weight loss on glycemic control, insulin release and resistance, and atherosclerotic risk in obese patients with type II diabetes mellitus. Am. J. Med. 1984; 77:7.
Leaf A., Weber P. Cardiovascular effects of n-3 fatty acids. N. Engl. J. Med. 1988; 318:549.
Uusitupa M.I.J., Laalso M., Sarlund H. and cois. Effects of a verylow- calorie diet on metabolic control cardiovascular rate factor in the treatment of obese non-insulin-dependent diabetes. Am. J. Clin. Nutr. 1990; 51:768.
Dobs a.S. y Margolis S. Diabetes y coronanopatía. Tribuna Médica 1990; 47:155.
Suh, L.L. y cois. Alcohol use and mortality from coronary heart disea- se:The role ofhigh-density lipoprotein. Ann. Int. Med. 1992; 116:881.
Mathews K.A., Meilahn E., Kuller L. H. and cois. Menopause and risk factores for coronary heart disease. N. Engl. J. Med. 1989; 321:641.
Walsh B.W., Shiff I., Rosner B. and cois. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N. Engl. J. Med. 1991; 325:1196.
